New Class of Factor VIII Replacement Therapy Prevents Bleeds in Severe Hemophilia A

(MedPage Today) -- Treatment with investigational efanesoctocog alfa (formerly BIVV001) -- a new class of factor VIII replacement therapy -- prevented bleeding episodes in patients with severe hemophilia A, according to results from the phase...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news